Reasons to Retain Quest Diagnostics (DGX) Stock for Now
https://www.zacks.com/stock/news/2267265/reasons-to-retain-quest-diagnostics-dgx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2267265
May 02, 2024 - Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
0
Hologic's (HOLX) Q2 Earnings Beat Estimates, 2024 View Up
https://www.zacks.com/stock/news/2268227/hologic-s-holx-q2-earnings-beat-estimates-2024-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2268227
May 03, 2024 - Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
0
Masimo (MASI) Q1 Earnings Beat Estimates, '24 EPS View Up
https://www.zacks.com/stock/news/2270706/masimo-masi-q1-earnings-beat-estimates-24-eps-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2270706
May 08, 2024 - Masimo's (MASI) Q1 healthcare revenues reflect strong sensor orders, which were completely offset by lower capital equipment purchases. Sensor production in Malaysia is likely to improve Healthcare gross margin.
0
Nevro's (NVRO) Q1 Earnings and Sales Beat Estimates, Margins Up
https://www.zacks.com/stock/news/2270793/nevro-s-nvro-q1-earnings-and-sales-beat-estimates-margins-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2270793
May 08, 2024 - Nevro's (NVRO) first-quarter earnings and revenues surpass their respective Zacks Consensus Estimate. The company incurs a loss in the operating level.
0
Philips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch
https://www.zacks.com/stock/news/2273683/philips-phg-gets-fda-recall-for-trilogy-ventilator-glitch?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2273683
May 14, 2024 - Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.
0
What's in Store for Cooper Companies (COO) in Q4 Earnings?
https://www.zacks.com/stock/news/2193818/what-s-in-store-for-cooper-companies-coo-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2193818
Dec 05, 2023 - Cooper Companies' (COO) fiscal fourth-quarter results are likely to reflect segmental strength.
0
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
https://www.zacks.com/stock/news/2208773/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2208773
Jan 11, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
0
Here's Why You Should Buy Align Technology (ALGN) Stock Now
https://www.zacks.com/stock/news/2209986/here-s-why-you-should-buy-align-technology-algn-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2209986
Jan 15, 2024 - Investors remain optimistic about Align Technology (ALGN) due to the progress in the Invisalign portfolio and highly favorable solvency.
0
Align Technology (ALGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2219129/align-technology-algn-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2219129
Jan 31, 2024 - Although the revenue and EPS for Align Technology (ALGN) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
0
Here's Why You Should Retain Align Technology (ALGN) Stock Now
https://www.zacks.com/stock/news/2229514/here-s-why-you-should-retain-align-technology-algn-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2229514
Feb 21, 2024 - Investors are optimistic about Align Technology (ALGN) on continued geographic expansion.
0
<Page 2